Euglycemic Diabetic Ketoacidosis Secondary to SGLT2-inhibitor Use in Combination With a Ketogenic Diet

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. Our case is an example that highlights the role SGL...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Hester, Joi C, Zimmerman, Stacy, Nimmo, Teresa Allison, Cunningham, Wesley, Liu, Joshua, Sukpraprut-Braaten, Suporn, Pasquel, Francisco J
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Diabetes Mellitus and Glucose Metabolism
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089890/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.776
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares